IPO registrations (S-1, F-1) · Registrants
BIOADAPTIVES, INC.
- SEC CIK
- 1575142 · filings on EDGAR ↗
- Former names
- APEX 8 Inc. (2013–2013)
- Registration
- Form S-1, first filed 2013-12-02, last 2014-01-07; 1 initial registration, 1 amendment
- Outcome
- Declared effective 2014-01-10
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 2620 REGATTA DRIVE, SUITE 102, Las Vegas, NV 89128
- EIN
- 46-2592228
- Ticker
- BDPT (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- BIOADAPTIVES, INC. on the corporate pages
Offering terms
- Shares offered
- 2,005,000
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: APEX 8 Inc. EXACT (CIK (EXACT))
Filings 3
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-12-02 | S-1 | S-1 (registration) | BIOADAPTIVES, INC. | 0001262463-13-000814 ↗ |
| 2014-01-07 | S-1/A | S-1/A (amendment) | BIOADAPTIVES, INC. | 0001262463-14-000020 ↗ |
| 2014-01-10 | EFFECT | EFFECT (declared effective) | BIOADAPTIVES, INC. | 9999999995-14-000095 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-01-07 | S-1/A | registration statement | $0.12 | 2,005,000 | $240,600 | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Chiang Richard | Director,Officer,TenPercentOwnerOther; Other | President,Secretary,Treasurer | 2 | 2013–2016 | |
| EPLING GERALD | Director,Officer | Pres, CEO, Secretary, CFO | 1 | 2013 | |
| EPLING BARRY | Director; Director,TenPercentOwner | 2 | 2013–2014 | ||
| FERRIS HOLDING INC. | TenPercentOwner; TenPercentOwnerOther | 2 | 2013–2014 | ||
| Dissanayake Gimhana Sasanka | Director | 1 | 2024 | ||
| FRISSORA MARK P | Director | 19 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | BIOADAPTIVES, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | BioAdaptives, Inc. | NV | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NV first:
- SKINVISIBLE, INC. NV
- CardioVascular BioTherapeutics, Inc. NV
- Praxsyn Corp NV
- EnzymeBioSystems NV
- CQENS Technologies Inc. NV
- BIOVIE INC. NV
- Mystic Holdings Inc./NV NV
- Option Therapeutics Inc. NV
- PHARMOS CORP NV
- SPECTRUM PHARMACEUTICALS INC NV
In other datasets, the same topic (Health) in NV:
- Nonprofit: ACTIVSTEM FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health